Phentolamine Injection 10mg/1mL

Phentolamine Injection 10mg | Alpha-Adrenergic Blocker
  • Dosage: Phentolamine Mesylate 10mg
  • Volume: 1 ml per  Ampoule
  • Packaging: 1 ampoule*10/tray*1 box*300/carton
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Product NamePhentolamine Injection
Specification10mg/1mL (10mg/mL)
Dosage FormSterile Solution for Injection
Active IngredientPhentolamine Mesylate
Pharmacological ClassAlpha-Adrenergic Receptor Antagonist (Alpha-Blocker)
Route of AdministrationIntravenous injection / infusion, or intramuscular injection
Packaging1mL amber glass ampoule
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Shelf Life36 months (unopened)

Product Overview

Phentolamine Injection 10mg/1mL is a sterile, aqueous solution of phentolamine mesylate intended for parenteral administration. Each 1mL ampoule contains 10mg of phentolamine (as phentolamine mesylate), providing a concentration of 10mg/mL. Phentolamine is a non-selective alpha-adrenergic receptor

Phentolamine Injection 10mg/1mL: What the Published Guidance Says

The resuscitation, antidote and critical-care injectables that a functioning emergency department cannot run without — most of them named directly on the WHO Model List.

Phentolamine Injection 10mg/1mL sits in the Emergency & Critical Care range. The notes below are the ones that most often change a specification, a label or a tender submission.

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Phentolamine Injection 10mg/1mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Phentolamine Injection 10mg/1mL — Supply Parameters

Product NamePhentolamine Injection
Specification10mg/1mL (10mg/mL)
Dosage FormSterile Solution for Injection
Active IngredientPhentolamine Mesylate
Pharmacological ClassAlpha-Adrenergic Receptor Antagonist (Alpha-Blocker)
Route of AdministrationIntravenous injection / infusion, or intramuscular injection
StorageStore below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use.
Therapeutic groupEmergency & Critical Care — Emergency & Critical Care
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Nimodipine Injection 10mg/50ml, Heparin Sodium Injection 2mL:5000IU, Citicoline Injection 2ml:250mg Ampoule, Aceglutamide Injection 100mg/5mL, Dobutamine Injection 12.5mg/mL 2mL, Diphenhydramine Injection 50mg/mL 2mL, Dexamethasone Injection 8mg/2mL, Acetylcysteine Injection 1g/5mL.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Phentolamine Injection 10mg/1mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for heavy metals and elemental impurities
  • Testing for packaging integrity and seal testing
  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: 1mL amber glass ampoule. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Documents for Phentolamine Injection 10mg/1mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

The context for Phentolamine Injection 10mg/1mL is its place among emergency and critical-care injectables named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

Frequently Asked Questions

What pack size is available for Phentolamine Injection 10mg/1mL?

This presentation is normally supplied as 1mL amber glass ampoule. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of Phentolamine Injection 10mg/1mL?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Phentolamine Injection 10mg/1mL support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Which of these emergency medicines are on the WHO Model List?

Epinephrine (adrenaline), atropine, dexamethasone injection, calcium gluconate, acetylcysteine, furosemide and heparin appear on the Model List. Confirm current listing for every molecule against the Model List and your national essential medicines list.

Do you supply acetylcysteine as the paracetamol antidote?

Yes. Acetylcysteine injection is available for paracetamol overdose management; the Model List names acetylcysteine among specific antidotes.

Related Emergency & Critical Care Products

Browse the full Emergency & Critical Care range; all Injectables; the complete product catalogue.

Request a Quotation for Phentolamine Injection 10mg/1mL

For tenders and programme supply, send the line item, pack size, quantity and destination for Phentolamine Injection 10mg/1mL 10mg. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products